Evidence map›Paper›PMID 24790153›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function.

Sumantha Bhatt, Jie Qin, Carole Bennett, Shiguang Qian, John J Fung, Thomas A Hamilton, Lina Lu

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Dendritic cells in liver transplantation immune response.Frontiers in cell and developmental biology · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sumantha BhattDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195;
Jie QinDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195;
Carole BennettDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; and.
Shiguang QianDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; Department of General Surgery, Transplantation Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195.
John J FungDepartment of General Surgery, Transplantation Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195.
Thomas A HamiltonDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; lul2@ccf.org hamiltt@ccf.org.
Lina LuDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; Department of General Surgery, Transplantation Center, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195 lul2@ccf.org hamiltt@ccf.org.

Funding

TELOMERASE INACTIVATION BY RNASE L SIGNALS CELL DEATHP01CA062220 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, GANES C. · 1994 to 2020
$35.6M
Post-transcriptional control of inflammatory gene expressionR01CA039621 · NCI · DUKE UNIVERSITY · PI HAMILTON, THOMAS A. · 1985 to 2013
$3.6M
Towards Induction of Cell Transplant ToleranceR01DK084192 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI LU, LINA · 2010 to 2014
$1.7M
Induction of Local Hyporesponsiveness: A Solution for Cell TransplantationR21AI090468 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI QIAN, SHIGUANG · 2010 to 2011
$430k
NCI NIH HHS CA039621NCI NIH HHS CA062220NCI NIH HHS P01 CA062220NCI NIH HHS R01 CA039621NIAID NIH HHS AI090468NIAID NIH HHS R21 AI090468NIDDK NIH HHS DK084192NIDDK NIH HHS R01 DK084192
6 · The paper itself

Abstract

Hepatic stellate cells (HSC) are a major source of the immunoregulatory metabolite all-trans retinoic acid (ATRA), which may contribute to the generation of tolerogenic dendritic cells (DCs) in the liver. The present study seeks to clarify the mechanism(s) through which ATRA promotes the development of tolerogenic DCs. Although bone marrow-derived ATRA-treated DCs (RA-DCs) and conventional DCs had comparable surface phenotype, RA-DCs had diminished stimulatory capacity and could directly inhibit the expansion of DC/OVA-stimulated OT-II T cells. Arginase-1 (Arg-1) was found promote suppression because 1) ATRA was a potent inducer of Arg-1 protein and activity, 2) the Arg-1 inhibitor N(w)-hydroxy nor-l-arginine partially reversed suppression, and 3) the suppressive function of RA-DCs was partially compromised using OT-II T cells from GCN2(-/-) mice, which are insensitive to Arg-1. Inducible NO synthase (iNOS), however, was found to be a more significant contributor to RA-DC function because 1) ATRA potentiated the expression of IFN-γ-induced iNOS, 2) suppressive function in RA-DCs was blocked by the iNOS inhibitor N(G)-monomethyl-l-arginine, monoacetate salt, and 3) RA-DCs derived from iNOS(-/-) mice exhibited near complete loss of tolerogenic function, despite sustained Arg-1 activity. The expression of iNOS and the suppressive function of RA-DCs were dependent on both IFN-γ and ATRA. Furthermore, the in vivo behavior of RA-DCs proved to be consistent with their in vitro behavior. Thus, we conclude that ATRA enhances both Arg-1 and iNOS expression in IFN-γ-treated DCs, resulting in a tolerogenic phenotype. These findings elucidate mechanisms through which ATRA may contribute to liver immune tolerance.

Indexed as

AnimalsAntineoplastic AgentsArginaseBone Marrow CellsDendritic CellsGene Expression Regulation, EnzymologicImmune ToleranceInterferon-gammaMiceMice, KnockoutNitric Oxide Synthase Type IIT-LymphocytesTretinoinAntineoplastic AgentsArg1 protein, mouseArginaseInterferon-gammaNitric Oxide Synthase Type IINos2 protein, mouseTretinoin

Identifiers

PMID24790153
PMCPMC4032093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.